Atieh Michael G
SEC-identified person · CIK 1072501 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Immatics N.V. IMTX | Director | filed 2026–2026 |
| Chubb Ltd CB | Director | filed 2006–2026 |
| Oyster Point Pharma, Inc. OYST | Director | filed 2020–2023 |
| Electrocore, Inc. ecor | Director | filed 2018–2021 |
| Ophthotech Corp. OPHT | EVP,CFO & CBO, Treasurer | filed 2014–2016 |
| Theravance Biopharma, Inc. tbph | Director | filed 2014–2014 |
| OSI Pharmaceuticals INC OSIP | Exec. VP & CFO | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.